GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Inventories, Raw Materials & Components

HLN (Haleon) Inventories, Raw Materials & Components : $298 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Haleon Inventories, Raw Materials & Components?

Haleon's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $298 Mil.

Haleon's quarterly raw materials stayed the same from Jun. 2024 ($0 Mil) to Sep. 2024 ($0 Mil) but then increased from Sep. 2024 ($0 Mil) to Dec. 2024 ($298 Mil).

Haleon's annual raw materials declined from Dec. 2022 ($378 Mil) to Dec. 2023 ($377 Mil) and declined from Dec. 2023 ($377 Mil) to Dec. 2024 ($298 Mil).

Haleon Inventories, Raw Materials & Components Historical Data

The historical data trend for Haleon's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Inventories, Raw Materials & Components Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 310.48 309.84 377.59 377.22 298.36

Haleon Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 377.22 - - - 298.36

Haleon Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Haleon Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (NYSE:HLN) » Definitions » Inventories, Raw Materials & Components
Comparable Companies
LSE:HIK LSE:HCM LSE:INDV LSE:APH LSE:AGY LSE:ANCR LSE:EAH LSE:STX LSE:PXS LSE:CEL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538
Traded in Other Exchanges
HLNCF:USA HLN1:Mexico HLN:Mexico HLNl:UK HLN:UK H6D0:Germany
Address
The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY
Website
https://www.haleon.com
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.